SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD APR 05
MCX SILVER MAY 05
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD APR 05
MCX SILVER MAY 05
MCX CRUDEOIL MAR 19
MCX NATURALGAS MAR 26
USD/INR
EUR/INR
GBP/INR
JPY/INR

Closing Bell: Sensex ends flat, Nifty above 14,950; energy stocks gain

Shares, dollar cheer US stimulus, bonds downcast

Brent cracks $70 for first time since pandemic began after Saudi facilities attacked

Rupee falls 14 paise to 73.16 against US dollar in early trade

Dabur Q1 net profit falls 5.9% to Rs 341.8 crore; volumes decline 9.7%

Updated : July 31, 2020 10:21 AM IST

Dabur's domestic volume during Q1FY21 declined at 9.7 percent versus expectations of 14-15 percent decline.

The quarter saw our new products record sales of over Rs 100 crore.

Dabur India reported a net 5.9 percent fall in net profit at Rs 341.8 crore for the quarter ended June 2020 crore as against Rs 363.1 crore in the same period last year. The profit beat CNBC-TV18 analysts' poll estimates of Rs 330 crore.

Revenue during the quarter declined 12.9 percent to Rs 1,980 crore from Rs 2,273.3 crore, YoY. Revenue was higher than estimates of Rs 1,975 crore.

Dabur's domestic volume in Q1FY21 fell at 9.7 percent versus expectations of 14-15 percent decline.

EBITDA fell 8.9 percent to Rs 416.6 crore from Rs 457.6 crore while EBITDA margin improved by 93 bps to 21.04 percent from 20.1 percent, year on year.

"Despite a challenging April, the quarter saw a nearly 7-fold growth in demand for Dabur Chyawanprash and an over 60% surge in demand for Dabur Honey. Dabur has significantly ramped up capacity with production now at near-normal levels and the business poised to deliver growth for the rest of the year," said Mohit Malhotra, Chief Executive Officer, Dabur India.

Dabur Chyawanprash reported a growth of over 694 percent during the quarter, while Dabur Honitus grew by over 80 percent while Dabur Honey ended Q1 2020-21 with a growth of over 60 percent.

The quarter saw Dabur introduce a record number of new products and variants anchored on the consumer need for Health, Immunity and Hygiene.

The quarter saw our new products record sales of over Rs 100 crore.

The OTC Healthcare Business ended the quarter with a 34 percent growth while the Ayurvedic Ethicals business was up 11 percent. The Toothpaste Business, on the back of continued demand for our flagship Dabur Red Paste, ended the quarter with a nearly 3 percent growth, it added.

Published : July 30, 2020 03:27 PM IST

You May Also Like

Punjab Budget: Government says will waive off loans worth Rs 1,186 crore of 1.13 lakh farmers

Punjab Budget: Government says will waive off loans worth Rs 1,186 crore of 1.13 lakh farmers

Easy Trip Planners IPO subscribed 1.09 times on day 1, retail portion at 5.97 times

Easy Trip Planners IPO subscribed 1.09 times on day 1, retail portion at 5.97 times

Govt mandates dual air bags in new models from April 1

Govt mandates dual air bags in new models from April 1

Trending on CNBC-TV18

Live TV

recommended for you